HEALTHPEAK PROPERTIES, INC. (DOC)
NYSE · Holding & Investment Offices · Real Estate Investment Trusts
- Price
- $20.72
- Day
- +1.92%
- Market cap
- $14.29B
- P/E
- 52.0
Close 2026-09-21.
The company
General Overview Healthpeak Properties, Inc. is a Standard & Poor’s (“S&P”) 500 company that owns, operates, and develops high-quality real estate focused on healthcare discovery and delivery in the United States (“U.S.”). Our company was originally founded in 1985. We are organized as an umbrella partnership REIT (“UPREIT”). We hold substantially all of our assets and conduct our operations through our operating subsidiary, Healthpeak OP, a consolidated subsidiary of which we are the managing member. We are a Maryland corporation and qualify as a self-administered REIT. We are headquartered in Denver, Colorado, with additional corporate offices in California, Tennessee, Wisconsin, and Massachusetts and property management offices in several locations throughout the U.S. We have a diversified portfolio of high-quality healthcare properties across three core asset classes of outpatient medical, lab, and senior housing real estate. Under the outpatient medical and lab segments, we own, operate, and develop outpatient medical buildings, hospitals, and lab buildings. Under the senior housing segment, our properties are operated through RIDEA structures. We have other non-reportable segments that are comprised primarily of: (i) loans receivable, (ii) a preferred equity investment, and (iii) three other properties . These non-reportable segments have been p resented on a combined basis herein. On March 1, 2024 (the “Closing Date”), we completed our merger with Physicians Realty Trust (the “Merger”).
From Item 1: General Overview.
Institutional holders
Largest positions reported on Form 13F for the quarter ended 2026-06-30, by value.
- VANGUARD PORTFOLIO MANAGEMENT LLC — $1.25B
- VANGUARD CAPITAL MANAGEMENT LLC — $963.32M
- STATE STREET CORP — $941.76M
- BlackRock, Inc. — $640.88M
- FULLER & THALER ASSET MANAGEMENT, INC. — $623.16M
- GEODE CAPITAL MANAGEMENT, LLC — $476.66M
- BlackRock, Inc. — $475.4M
- JPMORGAN CHASE & CO — $366.04M
Insider trades
Open-market buys and sales filed on Form 4, newest first. Grants, option exercises and tax withholding are left out.
- Bohn Scott R (CDO and Head of Lab) sold 10,989 shares at $19.45 on 2026-05-12
- Thomas John T (Director) bought 1,450 shares at $17.06 on 2025-08-06
- Brinker Scott M (President and CEO) bought 1,490 shares at $16.83 on 2025-08-04
- Brinker Scott M (President and CEO) bought 2,930 shares at $17.06 on 2025-07-31
- Brinker Scott M (President and CEO) bought 2,873 shares at $17.40 on 2025-07-28
- Thompson Tommy G (Director) bought 5,777 shares at $17.27 on 2025-05-28
Recent filings
- SCHEDULE 13G — 2026-08-07
- 10-Q — 2026-08-05
- 8-K — 2026-08-04
- SCHEDULE 13G/A — 2026-07-22
- 4 — 2026-06-02
- 4 — 2026-06-02
- 4 — 2026-06-02
- 4 — 2026-06-02
- 4 — 2026-06-02
- 4 — 2026-06-02